Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracellular ribavirin triphosphate concentrations in HCV/HIV-coinfected patients: influence of abacavir vs tenofovir
2008-001472-69Phase 4Active
- Sponsor
- Luis F. Lopez-Cortes
- Start
- May 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ribavirin in hepatitis C virus infection, Hepatitis C-related cirrhosis and human immunodeficiency virus infection (HIV) (2 arms), sponsored by Luis F. Lopez-Cortes. Primary endpoint: Intracellular ribavirin triphosphate concentrations. Started May 2008; status: active.
02
Drugs
ribavirin
03
Conditions
hepatitis C virus infectionHepatitis C-related cirrhosishuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2008-001472-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001472-69.